Ticker
VTGNCompany Name
VISTAGEN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -50.29M | $ -1.57 | 1 | 31.93M |
3/31/2025 | $ -42.29M | $ -1.37 | 1 | 30.88M |
12/31/2024 | $ -39.36M | $ -1.28 | 1 | 30.71M |
9/30/2024 | $ -33.65M | $ -1.1 | 1 | 30.63M |
6/30/2024 | $ -28.89M | $ -0.94 | 1 | 30.6M |
3/31/2024 | $ -25.87M | $ -1.34 | 1 | 19.35M |
12/31/2023 | $ -26.12M | $ -0.89 | 1 | 29.39M |
9/30/2023 | $ -31.5M | $ -3.61 | 1 | 8.72M |
6/30/2023 | $ -41.67M | $ -5.65 | 1 | 7.38M |
3/31/2023 | $ -49.93M | $ -7.17 | 1 | 6.96M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / (Shares WA * Share Factor)
(=) FCFPS
FCFPS for VISTAGEN THERAPEUTICS INC is calculated as follows: FCF [ $ -8.76M ] / (Shares WA [ 2.24M ] * Share Factor [ 1 ])
(=) FCFPS [ $ -3.92 ]
Minimum
Sep 30, 2022
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.76K |
---|---|
min | $ -7.96 |
max | $ 8.91 |
average | $ 0.81 |
median | $ 0.3 |
std | $ 2.83 |